237 related articles for article (PubMed ID: 26922979)
1. Percutaneous Ablation of Hepatic Tumors Using Irreversible Electroporation: A Prospective Safety and Midterm Efficacy Study in 34 Patients.
Niessen C; Beyer LP; Pregler B; Dollinger M; Trabold B; Schlitt HJ; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2016 Apr; 27(4):480-6. PubMed ID: 26922979
[TBL] [Abstract][Full Text] [Related]
2. CT-Guided Percutaneous Microwave Ablation of Tumors in the Hepatic Dome: Assessment of Efficacy and Safety.
Asvadi NH; Anvari A; Uppot RN; Thabet A; Zhu AX; Arellano RS
J Vasc Interv Radiol; 2016 Apr; 27(4):496-502; quiz 503. PubMed ID: 26922977
[TBL] [Abstract][Full Text] [Related]
3. Irreversible Electroporation of Malignant Hepatic Tumors--Alterations in Venous Structures at Subacute Follow-Up and Evolution at Mid-Term Follow-Up.
Dollinger M; Müller-Wille R; Zeman F; Haimerl M; Niessen C; Beyer LP; Lang SA; Teufel A; Stroszczynski C; Wiggermann P
PLoS One; 2015; 10(8):e0135773. PubMed ID: 26270651
[TBL] [Abstract][Full Text] [Related]
4. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures.
Cannon R; Ellis S; Hayes D; Narayanan G; Martin RC
J Surg Oncol; 2013 Apr; 107(5):544-9. PubMed ID: 23090720
[TBL] [Abstract][Full Text] [Related]
5. Ablation of perivascular hepatic malignant tumors with irreversible electroporation.
Kingham TP; Karkar AM; D'Angelica MI; Allen PJ; Dematteo RP; Getrajdman GI; Sofocleous CT; Solomon SB; Jarnagin WR; Fong Y
J Am Coll Surg; 2012 Sep; 215(3):379-87. PubMed ID: 22704820
[TBL] [Abstract][Full Text] [Related]
6. Irreversible electroporation for the ablation of liver tumors: are we there yet?
Charpentier KP
Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.
Kalra N; Gupta P; Gorsi U; Bhujade H; Chaluvashetty SB; Duseja A; Singh V; Dhiman RK; Chawla YK; Khandelwal N
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):584-590. PubMed ID: 30697637
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series.
Sutter O; Calvo J; N'Kontchou G; Nault JC; Ourabia R; Nahon P; Ganne-Carrié N; Bourcier V; Zentar N; Bouhafs F; Sellier N; Diallo A; Seror O
Radiology; 2017 Sep; 284(3):877-886. PubMed ID: 28453431
[TBL] [Abstract][Full Text] [Related]
10. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones.
Dollinger M; Jung EM; Beyer L; Niessen C; Scheer F; Müller-Wille R; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Oct; 25(10):1589-94. PubMed ID: 25156648
[TBL] [Abstract][Full Text] [Related]
11. Midterm Safety and Efficacy of Irreversible Electroporation of Malignant Liver Tumors Located Close to Major Portal or Hepatic Veins.
Distelmaier M; Barabasch A; Heil P; Kraemer NA; Isfort P; Keil S; Kuhl CK; Bruners P
Radiology; 2017 Dec; 285(3):1023-1031. PubMed ID: 28799842
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
[TBL] [Abstract][Full Text] [Related]
13. Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results.
Frühling P; Nilsson A; Duraj F; Haglund U; Norén A
Eur J Surg Oncol; 2017 Apr; 43(4):751-757. PubMed ID: 28109674
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system.
Hosein PJ; Echenique A; Loaiza-Bonilla A; Froud T; Barbery K; Rocha Lima CM; Yrizarry JM; Narayanan G
J Vasc Interv Radiol; 2014 Aug; 25(8):1233-1239.e2. PubMed ID: 24861662
[TBL] [Abstract][Full Text] [Related]
16. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique.
Park MJ; Kim YS; Rhim H; Lim HK; Lee MW; Choi D
J Vasc Interv Radiol; 2011 Jun; 22(6):771-9. PubMed ID: 21616430
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous ablation of peribiliary tumors with irreversible electroporation.
Silk MT; Wimmer T; Lee KS; Srimathveeravalli G; Brown KT; Kingham PT; Fong Y; Durack JC; Sofocleous CT; Solomon SB
J Vasc Interv Radiol; 2014 Jan; 25(1):112-8. PubMed ID: 24262034
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Irreversible Electroporation: Long-term survival analysis of 71 patients with inoperable malignant hepatic tumors.
Niessen C; Thumann S; Beyer L; Pregler B; Kramer J; Lang S; Teufel A; Jung EM; Stroszczynski C; Wiggermann P
Sci Rep; 2017 Mar; 7():43687. PubMed ID: 28266600
[TBL] [Abstract][Full Text] [Related]
19. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
20. Tumor Growth Kinetics and Oncologic Outcomes of Patients Undergoing Active Surveillance for Residual Renal Tumor following Percutaneous Thermal Ablation.
Chen JX; Maass D; Guzzo TJ; Bruce Malkowicz S; Wein AJ; Soulen MC; Clark TWI; Nadolski GJ; William Stavropoulos S
J Vasc Interv Radiol; 2016 Sep; 27(9):1397-1406. PubMed ID: 27234485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]